[Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants].
D000136:Acid-Base Equilibrium; D000925:Anticoagulants / Q000627:therapeutic use*; D000991:Antithrombins / Q000378:metabolism; D001792:Blood Platelets; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D001728:Dicumarol / Q000627:therapeutic use; D005172:Factor XI / Q000378:metabolism; D005174:Factor XII / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D006439:Hemodynamics; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology
D000925:Anticoagulants; D000991:Antithrombins; D001728:Dicumarol; D005174:Factor XII; D006493:Heparin; D005172:Factor XI; D005341:Fibrinolysin
Leczenie przeciwzakrzepowe w chorobach układu krazenia. I. Powstawanie zakrzepu i leki przec iwzakrzepowe.